Member Info for johnlaycock

From the same RNS:

As outlined in the Scottish Government announcement, approximately £800,000 will fund testing newborn babies with genedrive's MT-RNR-ID kit, in a phased national roll out over 18 months with first clinical testing beginning in October

Sounds like a national roll out to me Roger (given it says it is) !!

There was also a 2m buy on Thursday so someone may well be loading up....

I don't think they can delist without shareholder approval (75%). Turkeys don't vote for Christmas.

The Chairman has sold several businesses for hundreds of millions so you would assume he knows what he is doing!

....when we start getting some long overdue news on multiple fronts? I personally think as soon as one big ticket item lands (ie cyp2c19 national roll out, fda news or international orders) the company will be bought out by a bigger player.

It certainly is another indicator that Genedrive is in the right space in terms of the Gvts NHS priorities.

Someone is confident!

I think they were referring to MT-RNR1 not CYP2C19.

Eureka - (respectfully) national commissioning for CYP2C19 could not happen before the end of the pilot which was the end of May - NICE have confirmed that the implementation guidance for a national roll out will be published soon.

I don't think one is due. We are though due to hear very soon from NICE/NHSE on the national roll out of CYP2C19 testing and the national commissioning of the Genedrive PCT.

B_positive. Thanks. Can you please share the link to the post?

Good news - have had the following confirmed by Wallbrook on the phase 2 roll out of MT-RNR1:

- Genedrive is happy to confirm that the programme is progresses according to plan and that the scheduled phased go-live, which started in May, is on track.

- Genedrive have already disclosed that the phase 2 sites were to go live from May 2025 under the PALOH-UK NIHR programme. They do not intend to release further RNSs on these as it’s just business as usual under the programme, so they won't be releasing details of each site, location and when it is online.

- Genedrive are the technology partner in the programme and not the principal investigators and our experience with all other companies working with the NHS is that each location's media team are very protective about any publicity that names them and it would be for them to take the lead on the promotional side of things - it's fine once the specific NHS media team agree something and publicise it that Genedrive can then create their own PR.

Exactly. I think it will be before the end of June.

I've had a reply from the Implementation team at NICE to my enquiry when the implementation guidance will be published re CYP2C19 testing rollout - although they couldnt give me an exact date they did say it would be 'soon' (their exact words) !! This will be totally transformational for the company, if as we expect, the guidance will recommend a blend of lab and PCT (Genedrive) for a national roll out. The next few weeks will be very interesting!

EC it's a phased go live from May 2025 but we don't know the actual phasing. So it doesn't mean all 5 are live now.

Indeed. Bodes very well for next week. I have a suspicion we are going to get good news very soon..........

To go private, they would still need shareholders consent. I think most people here would accept 5p.

Except Slacker, both Genedrive's tests when adopted (shortly) across the NHS will save it money!

European sales to follow imminently. Mention in the RNS about routine use on Middle Eastern regions (note plural). Exciting times ahead.

Think it's a bit longer Jimi....2-3 days from the pilot study for lab results.